Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients

Clinical trial NCT02598999 · TERMINATED

Trial details

NCT number: NCT02598999
Sponsor: Alaxia SAS
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis Bronchiectasis

Start date: 2015-11-01
Primary completion: 2021-12-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.